Similarly, aberrant expression of oncogenic EGFR, which is responsible for the over-activation of GLI1 through RAS-RAF-MEK pathway, promotes colorectal cancer metastasis and chemotherapeutic resistance. This evidence concerns the gene GLI1 and colorectal cancer.